NEW YORK, October 25, 2016 /PRNewswire/ --
All eyes on this year's elections as states across the U.S. are positioned to vote whether to legalize the recreational use of
cannabis next year or not. Keep in mind the impact of the ballot measure's the passageway that would have direct results to
specific states. According to analytics provided by Gallup, the support for legal marijuana use is up to 60 percent in
the United States, marking it the highest percentage of support recorded in 47-year trend.
Favoring legalization is up among all age groups in the past decade and large majorities of Democrats and independents favor
legalization.
Bang Holding Corp. (OTC: BXNG), Cara Therapeutics Inc. (NASDAQ: CARA), Zynerba Pharmaceuticals Inc. (NASDAQ: ZYNE), Terra Tech
Corp. (OTC: TRTC), General Cannabis Corp. (OTC: CANN).
Individual voters will be analyzing such things as tax revenue implications, the general shift or perception of cannabis and
how the industry will have an effect on the general safety. With this in mind, the cannabis industry will experience a histrionic
change if even a few states permit legislation correlated to cannabis regulatory restructuring next month.
Bang Holdings Corporation (OTCQB: BXNG), through its subsidiary "Bang Digital Media", provides digital content and
inclusive marketing to the cannabis industry. Bang Digital Media promotes cannabis-related businesses to over a million
supporters by using its expanded network of cannabis-friendly social media influencers. Eventually, Bang Digital Media links
cannabis-friendly establishments to cannabis fanatics.
In mid-August, the company has reached a milestone of a million subscribers across its social networks and currently has over
1.25 million subscribers with its content being actively viewed more than 72.5 million times and significantly growing the
importance of its marketing network on a daily basis. The constant increase in the number of subscribers and its engagement, to
the Company's active community, new influencers it continues to sign, together with rapidly rising curiosity in cannabis
nationwide as several forms of its legalization are progressively escalating all across the states, including the District of Columbia.
"This is an incredibly exciting time for Bang," Steve Berke, CEO of Bang Holdings said. "Our
online content is attracting new users every day and surpassing one million subscribers proves we are significantly expanding the
reach, along with the advertising value, of our network. We are now settled in and are operating out of our regional production
office in Denver, the Epicenter of Ganjapreneurialism and home to so many innovators and
entrepreneurs in the cannabis industry, Berke added. "It enables us to better serve our industry customers locally, and to keep a
finger on the pulse of the newest market innovations and hottest trends."
Cannabis-focused agriculture company, Terra Tech Corp. (OTCQX: TRTC) announced that Blüm has opened a new retail
facility in the City of San Leandro, California. Blüm is a retail medical cannabis facility
concentrated on providing medical cannabis to patients who seek for alternative treatments for their chronic medical conditions.
Terra Tech expects to start construction of the new facility in January 2017. The new Blüm location
in San Leandro will considerably increase the accessibility of the Company's proprietary IVXX™
brand of premium medical cannabis, flowers, shatter, wax and oil, in addition to other superior grade medical cannabis products
from a range of trustworthy suppliers.
Clinical-stage biopharmaceutical company, Cara Therapeutics Inc. (NASDAQ: CARA), has reported that the effects of
cannabis has led to an endogenous system of ligands in individuals associated in a number of physiological processes that include
pain and inflammation. Cara owns CR701, a subsidiary performing cannabinoid receptor pain drug and CR845, Cara's top pain
treatment. Cara's Chief Medical Officer, Dr. Joseph Stauffer will also be participating at the
10th Annual Pain & Migraine Therapeutics Summit as well as at the ANESTHESIOLOGY® 2016 conference.
Clinical-stage pharmaceutical company devoted to the development of advanced transdermal synthetic cannabinoid treatments,
Zynerba Pharmaceuticals Inc. (NASDAQ: ZYNE) provided an update for its drug-adhesive matrix transdermal patch, ZYN001 and
synthetic CBD that is a patent-protected permeation-enhanced gel, the ZYN002. Zynerba will start Phase 1 clinical trials for
ZYN001 during the first half of 2017 and Phase 2 clinical trials will begin during the second half. As for ZYN002, three Phase 2
clinical trials will remain on schedule to report results during the first half of 2017. Two Phase 2 clinical trials are
currently ongoing for ZYN002, in adults with refractory epilepsy and in knee pain related with osteoarthritis. Phase 2 clinical
trials in patients with Fragile X Syndrome will start before the end of this year.
General Cannabis Corp. (OTCQB: CANN) is the all-in-one resource for top quality service providers available to the
regulated Cannabis Industry. CANN is a partner to the cultivation, production and retail side of the cannabis business. The
company does this through a combination of operating divisions such as real estate, consulting, security, financing and the
distribution of vital infrastructure products to cultivate facilities and dispensaries. As a holding company, its subsidiaries
are able to leverage the strengths of each other to succeed.
Subscribe Now! Watch us report from NYSE https://www.youtube.com/FinancialBuzzMedia
For "The Latest Buzz in Financial News", SIGN UP & Visit: http://www.FinancialBuzz.com
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
About FinancialBuzz.com
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News,
Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company
Interviews. A pioneer in the financially driven digital space, video production and integration of social media,
FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR branding, marketing and
advertising for third parties for disseminating news and original content through our unique media platform that includes
Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.
Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not
undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the "Site") is either original financial news or paid advertisements provided
[exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and pr marketing firm enters into
service agreements with the companies which are the subject to the articles posted on the Site for advertising such companies.
Financialbuzz.com has been compensated three thousand dollars for financial news dissemination and
pr services by a non-affiliated third party for bang holdings corp. We are not an independent news media provider and therefore
do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives
fees for producing and presenting high quality and sophisticated content on this site along with other financial news pr media
services. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this site, or a
combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance
is paid on or near the conclusion of the engagement. FinancialBuzz.com does not undertake to update any of the information on the
Site or continue to post information about any companies the information contained herein is not intended to be used as the basis
for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein
is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible
for any gains or losses that result from the opinions expressed on the Site, company profiles, quotations or in other materials
or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their
investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and
financial condition. FinancialBuzz.com. By accessing this website and any pages thereof, you agree to be bound by the Terms of
Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a
recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or
that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely
responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other
securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal
consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the
material provided. All materials are subject to change without notice. Information is obtained from sources believed to be
reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use. Please
visit: http://www.financialbuzz.com
For further information:
Media Contact: info@financialbuzz.com , +1-877-601-1879
SOURCE FinancialBuzz.com